Market Research Industry Today

Age-Related Vision Dysfunction Market Set to Witness Robust Growth – BIS Research

The global age-related vision dysfunction market is poised for strong expansion over the next decade. The increasing incidence of conditions such as age-related macular degeneration (AMD), presbyopia, cataracts, and glaucoma are fueling demand for diagnostics and therapeutics. New drug delivery systems, minimally invasive surgeries, and AI-powered screening tools are transforming the market landscape.
Published 23 June 2025

What Is the Market Outlook? 

The outlook is highly promising. Developed regions like North America and Europe are witnessing rapid adoption due to strong healthcare systems and early technology uptake. Meanwhile, Asia-Pacific is emerging as a key growth hub due to expanding healthcare access and aging populations. Innovations in teleophthalmology, regenerative therapies, and remote screening are further boosting potential across regions. 

How Fast Is the Market Growing? 

The market is growing steadily, driven by demographic shifts, rising prevalence of chronic eye conditions, and the adoption of next-gen diagnostic platforms. Increased insurance coverage and healthcare spending are accelerating the uptake of premium solutions, particularly in urban and semi-urban regions globally. 

How Will This Report Help You? 


Planning to Enter the Market? 

Identify emerging opportunities in AI-driven diagnostics, sustained-release ocular implants, and regenerative therapies across North America, Europe, and Asia-Pacific. 

Analyzing the Competitive Landscape? 

Benchmark key players such as Novartis, Alcon, Regeneron, and Genentech based on product pipelines, partnerships, and market penetration strategies. 

Seeking R&D Insights? 

Explore cutting-edge developments in gene and cell therapy, minimally invasive surgery tools, and smart ophthalmic devices powered by machine learning. 

Interested in Regional Market Trends? 

Access in-depth data segmented by therapy type, indication, and region, with insights into adoption trends across developed and emerging healthcare markets. 

Explore the Full TOC and Download Report Sample 


What Technologies Are Transforming the Market? 


  • AI-based Diagnostics: Automating detection of degenerative eye diseases with high accuracy. 
  • Sustained-Release Implants: Delivering drugs over extended periods with fewer procedures. 
  • Minimally Invasive Surgery: Improving recovery times and outcomes for cataract and glaucoma management. 
  • Gene and Cell Therapy: Offering new hope for irreversible retinal damage and inherited disorders. 


What’s Driving Demand and What Are the Barriers? 


Key Drivers: 


  • Aging Populations: Growing number of elderly individuals susceptible to vision disorders. 
  • Tech Advancements: Enhanced imaging, diagnostics, and surgical innovations. 
  • Public Health Initiatives: Campaigns promoting regular eye exams and preventive care. 
  • Rising Diabetes Incidence: Fueling demand for diabetic retinopathy screening and care. 


Major Barriers: 


  • High Cost: Premium treatments and devices may remain out of reach in low-income settings. 
  • Infrastructure Gaps: Lack of access to trained ophthalmologists in rural and emerging areas. 
  • Regulatory Hurdles: Lengthy approval processes for novel biologics and implants. 


Download the complete TOC now! 


Who Are the Key Players? 

Key companies in this market include: 

• Genentech 

• Kodiak Sciences 

• Outlook Therapeutics 

• AbbVie, Inc. 

• Alimera Science 


Strategic Moves Shaping the Future 

Industry players are focusing on AI integration, portable diagnostic tools, and global expansion. Collaborations for gene therapy development, investments in ophthalmic imaging startups, and localized manufacturing in Asia-Pacific are redefining access and affordability. 

Case Study 

A major ophthalmology chain implemented an AI-based diagnostic tool across its network. The result was faster diagnosis of macular degeneration, earlier intervention, and improved patient retention. By reducing delays in treatment, they enhanced both patient satisfaction and long-term clinical outcomes showcasing the value of digital innovation in ophthalmic care. 

Schedule a Call with Industry Experts 


Related Reports from BIS Research 

Intermediate Age-Related Macular Degeneration Market 

Wet Age-Related Macular Degeneration (Wet AMD) Market 

Dry Age-Related Macular Degeneration Market 

About BIS Research 

BIS Research is a global B2B market intelligence and advisory firm focusing on deep technology and related emerging trends, which can disrupt the market dynamics in the near future. We publish over 200 market intelligence studies annually, focusing on several deep technology verticals.   

Our strategic market analysis emphasizes market estimations, technology analysis, emerging high-growth applications, deeply segmented granular country-level market data, and other important market parameters useful in the strategic decision-making for senior management.    

BIS Research offers syndicate and custom studies and expert consultations to firms, providing them with specific and actionable insights on novel technology markets, business models, and competitive landscapes.   


Contact 

Head of Marketing  

Email: media@bisresearch.com    

BIS Research Inc.   

39111 PASEO PADRE PKWY STE 313,   

FREMONT, CA 94538-1686  


Visit our Blog @https://bisresearch.com/insights   

Get Expert Insights @https://community.insightmonk.com    

Connect with us on LinkedIn @ https://www.linkedin.com/company/bis-research    

Connect with us on Twitter@ https://twitter.com/BISResearch   



Other Industry News

Ready to start publishing

Sign Up today!